otolith labs funding 20 million

Otolith Labs Raises $20M Series A to Develop Wearable Vertigo Treatment Device

WASHINGTON D.C.  — Otolith Labs, a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, announced the closing of a $20 million Series A financing round by Morningside Ventures. Building on prior investments from businessman Mark Cuban and leading ENT physicians, the proceeds will be used to support the company’s…

Read More
tinnitus worse covid-19

New Study Confirms Link Between COVID-19 and Symptoms of Hearing Loss, Tinnitus and Vertigo

by Kevin Munro, University of Manchester Some viruses, such as measles, mumps and meningitis, can cause hearing difficulties, but what about SARS-CoV-2, the virus that causes COVID-19? In the first few months of the pandemic, a rapid systematic review of COVID-19 and hearing difficulties revealed a possible link between COVID-19 and audio-vestibular symptoms (hearing loss, tinnitus and vertigo).…

Read More
vitamin d prevents vertigo

Study: Taking Regular Vitamin D Supplements May Prevent Vertigo from Recurring

MINNEAPOLIS, MINNESOTA – Taking vitamin D and calcium twice a day may reduce your chances of getting vertigo again, according to a study published in the August 5, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. “Our study suggests that for people with benign paroxysmal positional vertigo, taking a supplement…

Read More
auris medical

Auris Medical Announces Completion of Enrollment in Phase 2 Study for Vertigo Drug, AM-125

Auris Medical Holding Ltd., a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, announced the completion of patient enrollment into Part A of its Phase 2 “TRAVERS” trial with intranasal betahistine in vertigo (AM-125). The company says that it expects to release interim results…

Read More
vestibular migraine dizziness

Non-invasive Nerve Stimulation May Help Provide Relief During Vestibular Migraine Attacks

MINNEAPOLIS, MINNESOTA – A small preliminary study suggests that non-invasive nerve stimulation may hold promise as a treatment for vestibular migraine attacks. A vestibular migraine is a type of migraine that causes vertigo and dizziness with or without headache pain, a condition for which there are currently no approved treatments. The new study was published…

Read More
cava headset vertigo diagnosis

Researchers Develop New, Highly Accurate, Diagnostic Headset for Dizziness

UK researchers, from the University of East Anglia and Norfolk and Norwich University Hospital, have developed a wearable headset for diagnosing dizziness. A clinical investigation of the Continuous Ambulatory Vestibular Assessment (CAVA) device was recently published in the journal Scientific Reports. After capturing 9000 hours of eye and head movement data from a group of…

Read More

Sensorion to Begin Patient Enrollment for Safety Study of Vertigo Drug, Seliforant

MONTPELLIER, FRANCE — Biotech firm Sensorion announced the initiation of patient enrollment in a Phase 2a study (SENS-111-202) to confirm the absence of certain side effects commonly experienced with meclizine (specifically, anticholinergic side effects like sedation and memory loss) during an evoked vestibular imbalance. SENS-111-202 is a randomized, double-blind, double-dummy, placebo-controlled, cross-over trial in patients designed…

Read More
dizzy vertigo treatment

Researchers Discover New Form of Vertigo That Can be Treated

As many audiologists know, vertigo has a myriad of causes and the treatment process can be complex and time-consuming. Researchers in South Korea, however, have identified a new type of vertigo that may be effectively treated with medication. A study, published online last week in the journal Neurology identified what they consider a new condition,…

Read More
bppv vertigo guidelines

New Best Practice Guidelines Issued for BPPV, One of the Most Common Causes of Vertigo

ALEXANDRIA, VIRGINIA — On March 1st, the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) published an updated clinical practice guideline for healthcare providers on benign paroxysmal positional vertigo (BPPV). The updated guideline, Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo, provides evidence-based recommendations to healthcare providers on diagnosis and treatment of BPPV. Additionally, the…

Read More